- Home
- STRR vs CPHI Comparison
STRR vs CPHI Comparison
Compare STRR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- CPHI
- Stock Information
- Founded
- STRR 1985
- CPHI N/A
- Country
- STRR United States
- CPHI China
- Employees
- STRR N/A
- CPHI N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- STRR Health Care
- CPHI Health Care
- Exchange
- STRR Nasdaq
- CPHI Nasdaq
- Market Cap
- STRR 6.3M
- CPHI 7.3M
- IPO Year
- STRR N/A
- CPHI N/A
- Fundamental
- Price
- STRR $2.00
- CPHI $1.78
- Analyst Decision
- STRR Strong Buy
- CPHI
- Analyst Count
- STRR 1
- CPHI 0
- Target Price
- STRR $5.00
- CPHI N/A
- AVG Volume (30 Days)
- STRR 21.4K
- CPHI 152.1K
- Earning Date
- STRR 08-12-2025
- CPHI 08-13-2025
- Dividend Yield
- STRR N/A
- CPHI N/A
- EPS Growth
- STRR N/A
- CPHI N/A
- EPS
- STRR N/A
- CPHI N/A
- Revenue
- STRR $57,165,000.00
- CPHI $4,295,377.00
- Revenue This Year
- STRR $33.64
- CPHI N/A
- Revenue Next Year
- STRR $22.87
- CPHI N/A
- P/E Ratio
- STRR N/A
- CPHI N/A
- Revenue Growth
- STRR 34.33
- CPHI N/A
- 52 Week Low
- STRR $1.72
- CPHI $1.20
- 52 Week High
- STRR $5.35
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- STRR 45.82
- CPHI 50.11
- Support Level
- STRR $1.95
- CPHI $1.55
- Resistance Level
- STRR $2.02
- CPHI $1.91
- Average True Range (ATR)
- STRR 0.07
- CPHI 0.18
- MACD
- STRR -0.00
- CPHI 0.02
- Stochastic Oscillator
- STRR 36.84
- CPHI 53.45
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.